Impact of recent black box warnings in the allergy world.

Suppr

超能文献

作者信息

Oppenheimer John, Aaronson Donald

机构信息

Pulmonary and Allergy Associates PA, Cedar Knolls, New Jersey 07927, USA.

出版信息

Ann Allergy Asthma Immunol. 2007 Oct;99(4):364-6. doi: 10.1016/S1081-1206(10)60554-6.

DOI:10.1016/S1081-1206(10)60554-6

PMID:17941285

Abstract

摘要

相似文献

Impact of recent black box warnings in the allergy world.

Ann Allergy Asthma Immunol. 2007 Oct;99(4):364-6. doi: 10.1016/S1081-1206(10)60554-6.

The "black box" warning and allergy drugs.

J Allergy Clin Immunol. 2006 Jan;117(1):40-4. doi: 10.1016/j.jaci.2005.08.060.

Primum non nocere and "black box" warnings.

J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2.

Topical calcineurin inhibitors labeling: putting the "box" in perspective.

Arch Dermatol. 2006 Sep;142(9):1233-5. doi: 10.1001/archderm.142.9.1233.

Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.

N Engl J Med. 2009 Apr 16;360(16):1592-5. doi: 10.1056/NEJMp0810561.

Black box warning for topical calcineurin inhibitors and the death of common sense.

Dermatol Online J. 2006 Oct 31;12(6):2.

Topical calcineurin inhibitors revisited.

Arch Dermatol. 2007 Apr;143(4):545-6. doi: 10.1001/archderm.143.4.545.

FDA LABA warning: is there anything new here?

Clin Pharmacol Ther. 2010 Jun;87(6):638-9. doi: 10.1038/clpt.2010.58.

Differences in physicians' self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting beta-agonists.

Ann Allergy Asthma Immunol. 2009 Oct;103(4):304-10. doi: 10.1016/S1081-1206(10)60529-7.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Impact of recent black box warnings in the allergy world.

Ann Allergy Asthma Immunol. 2007 Oct;99(4):364-6. doi: 10.1016/S1081-1206(10)60554-6.

The "black box" warning and allergy drugs.

J Allergy Clin Immunol. 2006 Jan;117(1):40-4. doi: 10.1016/j.jaci.2005.08.060.

Primum non nocere and "black box" warnings.

J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2.

Topical calcineurin inhibitors labeling: putting the "box" in perspective.

Arch Dermatol. 2006 Sep;142(9):1233-5. doi: 10.1001/archderm.142.9.1233.

Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values.

N Engl J Med. 2009 Apr 16;360(16):1592-5. doi: 10.1056/NEJMp0810561.

Black box warning for topical calcineurin inhibitors and the death of common sense.

Dermatol Online J. 2006 Oct 31;12(6):2.

Topical calcineurin inhibitors revisited.

Arch Dermatol. 2007 Apr;143(4):545-6. doi: 10.1001/archderm.143.4.545.

FDA LABA warning: is there anything new here?

Clin Pharmacol Ther. 2010 Jun;87(6):638-9. doi: 10.1038/clpt.2010.58.

Differences in physicians' self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting beta-agonists.

Ann Allergy Asthma Immunol. 2009 Oct;103(4):304-10. doi: 10.1016/S1081-1206(10)60529-7.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.